RxDoctor Payments Data

King Coffield

Urology · Temple, TXNPI 1487614376

Payments from drug & device makers

What this record shows

Pfizer accounts for 85.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,449 and has fallen 94.1% since, to $86 in 2021. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.

$1,627in general payments, 2019–2025

Across 8 payments — averaging $203.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • Photocure Inc$97
  • Myriad Genetic Laboratories, Inc.$86
  • Johnson & Johnson$49
$493,246in research payments, 2019–2025

Across 31 payments — averaging $15,911 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$434K
  • E.r. Squibb & Sons, L.L.C.$36K
  • Artivion, Inc.$24K
  • Urovant Sciences Inc$250

What the payments were for

  • Travel & lodging$84352%
  • Food & beverage$78448%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,627 in reported general payments places this provider in the 30th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Other urology in Temple

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →